Trailing Dividend / Share
$0.00
BioMarin Pharmaceutical Inc. (BMRN) Dividend History
Income profile from 1998 to 2025 with payout safety and yield-on-cost trend
Dividend Yield
N/A
Payout Ratio
N/A
Unknown
Dividend Streak
0 years
3-Second Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
Dividend Scorecard
Yield & Income
Dividend YieldN/A
Trailing DPS$0.00
FrequencyN/A
Payments / 12M0
Payout Safety
Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score5/9
Growth
Growth Streak0 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown
Total Returns
Buyback Yield0.0%
Total Shareholder Yield0.0%
1Y Total Return-13.3%
5Y Total Return-22.0%
Estimated $10K growth (return + dividends):
5Y ago$7,79710Y ago$7,54020Y ago$47,194
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). BMRN's recent 5Y regime has been stronger than its full 10Y period, so 5Y can appear higher than 10Y.
Dividend History
No dividend payment history available
This company has not paid dividends during the available data period.
Dividend Analysis
Payout Safety
BioMarin Pharmaceutical Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 5/9 — moderate financial health.
Growth Track Record
BMRN does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, BMRN returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is -22.0%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $7,540 today.
Annual Dividend History
28 years of dividend data
GrowthDecline
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $0.14 | — | — | — |
| 2024 | $0.00 | — | 0 | $2.21 | — | — | — |
| 2023 | $0.00 | — | 0 | $0.88 | — | — | — |
| 2022 | $0.00 | — | 0 | $0.75 | — | — | — |
| 2021 | $0.00 | — | 0 | $-0.35 | — | — | — |
| 2020 | $0.00 | — | 0 | $4.53 | — | — | — |
| 2019 | $0.00 | — | 0 | $-0.13 | — | — | — |
| 2018 | $0.00 | — | 0 | $-0.44 | — | — | — |
| 2017 | $0.00 | — | 0 | $-0.67 | — | — | — |
| 2016 | $0.00 | — | 0 | $-3.79 | — | — | — |
See BMRN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BMRN Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare BMRN vs AGIO
See how BMRN stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How much dividend does BMRN pay per share?
BioMarin Pharmaceutical Inc. (BMRN) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is BMRN's next ex-dividend date?
BMRN's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. BMRN typically pays dividends quarterly.
Is BMRN's dividend safe?
BMRN's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has BMRN increased its dividend?
BMRN has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does BMRN pay dividends?
BioMarin Pharmaceutical Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 27+ years from 1998 to 2025.
How much would $10,000 invested in BMRN grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in BMRN five years ago would be worth approximately $7,797 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is BMRN's yield on cost for long-term holders?
BMRN's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.